Seventure Partners logo

Seventure Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

8

Common Fundraising Type

Series B

Karmen logo
Karmen

Revenue-based financing

Seventure Partners logo
Financi 
 re Arbevel logo
Bpifrance logo

Karmen provides revenue-based financing solutions for small and medium-sized enterprises (SMEs) facing cash flow challenges, using a data-driven approach to assess and manage loan risks.

Hybrid
$9.3M
01/21/2025
Article
FIRE1 logo
FIRE1

Connected medical device

Polaris Partners logo
Elevage Medical Technologies logo
Seventure Partners logo
Sands Capital logo
Novo Holdings logo
NEA logo
Medtronic logo
Lightstone Ventures logo

FIRE1 is a connected medical device solutions company focused on developing a heart failure management platform that enables patient self-management and reduces healthcare burdens.

Equity
$120M
01/07/2025
Article
bsport logo
bsport

Technology platform

Stanford University logo
Seventure Partners logo
Seed4Soft logo
Octopus Ventures logo
Base10 Partners logo

bsport provides a comprehensive technology platform for the boutique wellness industry, integrating software, marketing automation, data insights, and studio management tools.

Series B
$31.4M
12/13/2024
Article
Citryll logo
Citryll

Biotech

Forbion logo
Novartis logo
Johnson & Johnson Innovation logo
Seventure Partners logo
Pureos Bioventures logo
Curie Capital logo
BioGeneration Ventures logo
BOM logo

Citryll is a biotech company developing therapies for immune-mediated inflammatory diseases, focusing on a monoclonal antibody targeting Neutrophil Extracellular Traps (NETs).

Series B
$89.8M
12/09/2024
Article
Siit logo
Siit

AI-powered

Seventure Partners logo
StageOne Ventures logo

Siit provides an AI-powered service desk solution that automates routine tasks and streamlines operations for IT and internal teams.

Seed
$5M
11/07/2024
Article

Sequentia Biotech develops advanced bioinformatics platforms for data analysis and interpretation in genomics, transcriptomics, epigenomics, and microbiomics, enhancing applications in biomedicine, agritech, and the food industry.

Series A
$11.2M
09/30/2024
Article
Eligo Bioscience logo
Eligo Bioscience

Gene-editing

Sanofi Ventures logo
Bpifrance logo
Khosla Ventures logo
Seventure Partners logo

Eligo Bioscience is a gene-editing biotech company focused on developing precision medicines for immuno-inflammation, oncology, and infectious diseases by leveraging microbiome in-vivo gene editing technologies.

Series B
$30M
12/05/2023
Article
AYRO logo
AYRO

Maritime Industry

SWEN Capital Partners logo
Ocean Zero logo
Normandie Participations logo
Normandie Littoral logo
FCPI Capital Innovant n°2 logo
Colam Impact logo
Bpifrance logo
AmInvest logo

AYRO is a company that designs and manufactures wind-powered decarbonation solutions for the maritime sector, aiming to reduce emissions in the shipping industry.

Series B
$20.3M
09/26/2023
Article